Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures

European Cytokine Network

Volumn 13, Issue 1, 2002, Pages 39-45

  Ramalho, Ana Claudia ^a   Couttet, Philippe ^a   Baudoin, Claude ^a   Morieux, Caroline ^a   Graulet, Anne Marie ^a   De Vernejoul, Marie Christine ^a   Cohen Solal, Martine E ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Apoptosis; Cytokines; Estrogen receptor; Osteoclast; SERM

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ESTRADIOL; ESTROGEN RECEPTOR; INTERLEUKIN 6; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

APOPTOSIS; ARTICLE; BONE MARROW CULTURE; BONE TURNOVER; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MONONUCLEAR CELL; MULTINUCLEAR CELL; OSTEOCLAST; OSTEOLYSIS; POSTMENOPAUSE;

APOPTOSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; INTERLEUKIN-6; OSTEOCLASTS; RALOXIFENE; RECEPTORS, ESTROGEN; RECEPTORS, INTERLEUKIN; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SELECTIVE ESTROGEN RECEPTOR MODULATORS; STEM CELLS;

EID: 0036091003     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. The prevention and treatment of osteoporosis
2. Bone marrow, cytokines and bone remodeling. Emerging insights into pathophysiology of osteoporosis
3. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone
4. Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under suitable microenvironment prepared by bone marrow-derived stromal cells
5. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
6. 17β-estradiol inhibits interleukin-6 production by bone marrow -derived stromal cells and osteoblasts in vitro: A potential mechanism for antiosteoporotic effect of estrogens
7. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and tumor necrosis factor-α: Lack of regulation by 17β-estradiol
8. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovarectomy
9. Cytokine production in the bone marrow microenvironment: Failure to demonstrate estrogen regulation in early postmenopausal women
10. Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: Involvement of cytokines
11. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
12. The cancer question: An overview of recent epidemiologic and retrospecitive data
13. The role of estrogen and progestagens in the epidemiology and prevention of breast cancer
14. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer
15. A controlled trial of raloxifene (LY139481) HCL: Impact on bone turnover and serum lipid profile in healthy postmenopausal women
16. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
17. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells
18. Estrogen inhibits bone resorption resorption by directly inducing apoptosis of bone resorbing osteoclast
19. Messenger RNA deadenylylation precedes decapping in mammalian cell
20. Regulation of osteoclast function
21. Bone resorption at the femoral neck is dependent on local factors in non-osteoporotic late postmenopausal women: An in vitro-in vivo study
22. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice
23. Inhibition of bone resorption by 17β-estradiol in human bone marrow cultures
24. Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia
25. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERβ (-/-) mice
26. Estrogen receptor-α knockout mice lose trabecular and cortical bone following ovariectomy
27. Differential expression of estrogen receptor α and β messenger RNAs as a potential marker of ovarian carcinogenesis
28. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone
29. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β